Tanaka Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$203K Sell
6,714
-178
-3% -$5.38K 0.48% 22
2024
Q4
$241K Sell
6,892
-7,620
-53% -$266K 0.55% 24
2024
Q3
$581K Hold
14,512
1.34% 20
2024
Q2
$692K Sell
14,512
-100
-0.7% -$4.77K 1.64% 17
2024
Q1
$633K Hold
14,612
1.56% 19
2023
Q4
$739K Hold
14,612
1.81% 18
2023
Q3
$663K Buy
14,612
+7,500
+105% +$340K 1.89% 16
2023
Q2
$292K Hold
7,112
0.79% 23
2023
Q1
$254K Hold
7,112
0.74% 24
2022
Q4
$269K Hold
7,112
0.85% 23
2022
Q3
$315K Hold
7,112
0.94% 23
2022
Q2
$263K Sell
7,112
-1,435
-17% -$53.1K 0.86% 22
2022
Q1
$317K Sell
8,547
-315
-4% -$11.7K 0.64% 25
2021
Q4
$270K Sell
8,862
-7,799
-47% -$238K 0.51% 27
2021
Q3
$559K Hold
16,661
0.8% 26
2021
Q2
$665K Sell
16,661
-3,950
-19% -$158K 0.9% 21
2021
Q1
$927K Buy
20,611
+3,805
+23% +$171K 1.18% 18
2020
Q4
$950K Sell
16,806
-1,715
-9% -$96.9K 2.11% 11
2020
Q3
$879K Sell
18,521
-1,008
-5% -$47.8K 2.75% 10
2020
Q2
$1.15M Sell
19,529
-511
-3% -$30.1K 3.57% 7
2020
Q1
$947K Sell
20,040
-10,067
-33% -$476K 4.14% 7
2019
Q4
$1.82M Sell
30,107
-570
-2% -$34.4K 5.77% 5
2019
Q3
$1.84M Sell
30,677
-1,993
-6% -$119K 5.93% 3
2019
Q2
$2.1M Sell
32,670
-1,721
-5% -$111K 6.43% 3
2019
Q1
$2.79M Sell
34,391
-2,069
-6% -$168K 8.42% 2
2018
Q4
$1.97M Sell
36,460
-275
-0.7% -$14.9K 6.27% 5
2018
Q3
$1.9M Hold
36,735
4.4% 6
2018
Q2
$1.53M Sell
36,735
-13,515
-27% -$563K 3.67% 10
2018
Q1
$2.22M Sell
50,250
-2,231
-4% -$98.3K 5.3% 7
2017
Q4
$2.64M Sell
52,481
-9,620
-15% -$484K 6.03% 5
2017
Q3
$3.15M Sell
62,101
-19,836
-24% -$1.01M 7.02% 4
2017
Q2
$4.17M Sell
81,937
-1,462
-2% -$74.4K 9.55% 2
2017
Q1
$3.35M Sell
83,399
-1,554
-2% -$62.5K 7.39% 3
2016
Q4
$4.06M Buy
84,953
+20,183
+31% +$965K 9.51% 1
2016
Q3
$2.37M Buy
+64,770
New +$2.37M 5.69% 6